Schürrle, Seval Beykan
Eberlein, Uta
Ansquer, Catherine
Beauregard, Jean-Mathieu
Durand-Gasselin, Lucie
Grønbæk, Henning
Haug, Alexander
Hicks, Rodney J.
Lenzo, Nat P.
Navalkissoor, Shaunak
Nicolas, Guillaume P.
Pais, Ben
Volteau, Magali
Wild, Damian
McEwan, Alexander
Lassmann, Michael
Funding for this research was provided by:
Ipsen (Ipsen)
Article History
Received: 2 November 2023
Accepted: 8 March 2024
First Online: 26 March 2024
Declarations
:
: <b>SBS, UE</b>: None to declare. <b>CA</b>: Received personal and consulting fees from Novartis/AAA. <b>JMB</b>: Received honoraria and/or consulting fees from Ipsen and Novartis/AAA. <b>LDG</b>: Employee of Ipsen. <b>HG</b>: Received research grants from Abbvie, Intercept, ARLA Food for Health, and ADS AIPHIA Development Services. <b>AH</b>; Received consulting fees from Ipsen, NOVO, and Pfizer; lectures for AstraZeneca and EISAI; and serves on the Data Monitoring Committee at IQVIA. <b>RJH</b>: Has shares in Telix Pharmaceuticals. <b>NPL</b>: None to declare. <b>SN</b>: Received honoraria and/or consulting fees from Ipsen and Novartis/AAA. <b>GPN</b>: None to declare. <b>BP</b>: Consultant to Ariceum and was employed by Ipsen at the time of study initiation. <b>MV</b>: Employee of Ipsen. <b>DW</b>: Received personal fees from Ipsen and grants from Siemens Healthineers. <b>AM</b>: Employee of Ariceum and was employed by Ipsen at the time of study initiation. <b>ML</b>: Received institutional grants from Ipsen, Nordic Nanovector, Novartis and PentixaPharm.
: All procedures involving human participants were carried out in accordance with the ethical standards of the institutional and/or national research committees and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This article does not contain any experiments with animals.
: Written informed consent was obtained from all individual participants included in the study.
: Not applicable.